Patient selection for transcatheter aortic valve replacement

Journal of the American College of Cardiology

Volumn 62, Issue 17 SUPPL, 2013, Pages

  Mack, Michael J ^a   Holmes, David R ^b   Webb, John ^c   Cribier, Alain ^d   Kodali, Susheel K ^e,f   Williams, Mathew R ^e,f   Leon, Martin B ^e,f  

^a BAYLOR HEALTH CARE SYSTEM   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITÉ DE ROUEN   (France)

^e NewYork Presbyterian Hospital   (United States)

^f CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

cardiac surgery; clopidogrel; CYP2C19; genetics; interventional cardiology; platelet function; prasugrel; ticagrelor; transcatheter aortic valve replacement

Indexed keywords

AORTA STENOSIS; AORTA VALVE PROSTHESIS; DEVICE APPROVAL; DISEASE SEVERITY; EDUCATION PROGRAM; HEALTH CARE POLICY; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL COOPERATION; MEDICAL DOCUMENTATION; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL SOCIETY; MEDICARE; PATIENT SAFETY; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 84886638853     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.08.707     Document Type: Review

References (39)

1. Leon MB, Smith CR, Mack M, et al., for the PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363: 1597-607.
2. Smith CR, Leon MB, Mack MJ, et al., for the PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98.
3. Makkar RR, Fontana GP, Jilaihawi H, et al., for the PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012;366:1696-704.
4. Kodali SK, Williams MR, Smith CR, et al., for the PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aorticvalve replacement. N Engl J Med 2012;366:1686-95.
5. U.S. Food and Drug Administration. 2011 Meeting Materials of the Circulatory System Devices Panel. 2011. Available at: http://www. fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovals andClearances/Recently-ApprovedDevices/ucm280840.htm. Accessed August 28, 2013.
6. Holmes DR, Mack MJ, Writing Committee. Transcatheter valve therapy: a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons. Ann Thorac Surg 2011;92:380-9.
7. Holmes DR, Mack MJ. Transcatheter valve therapy: a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons. J Am Coll Cardiol 2011;58:445-55.
8. Tommaso CL, Bolman RM 3rd, Feldman T, et al. Multisociety (AATS, ACCF, SCAI, and STS) expert consensus statement: operator and institutional requirements for transcatheter valve repair and replacement, part 1: transcatheter aortic valve replacement. J Am Coll Cardiol 2012;59:2028-42.
9. Holmes DR Jr., Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/ STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 2012;59:1200-54.
10. Centers for Medicare and Medicaid Services. Available at: http://www. cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?http://www. cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?&NcaName= Transcatheter%20Aortic%20Valve%20Replacement%20 %28TAVR%29&bc= AiAAAAAAIAAA&NCAId=257. Accessed August 29, 2013.
11. STS/ACC TVT Registry. Home page. Available at: www.tvtregistry. org. Accessed August 29, 2013.
12. Carroll JD, Edwards FH, Marinac-Dabic D, et al. The STSACC Transcatheter Valve Therapy National Registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. J Am Coll Cardiol 2013;62: 1026-34.
13. Leon MB, Smith CR, Mack M, et al., for the PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.NEngl J Med 2010;363:1597-607.
14. Jilaihawi H, Chakravarty T, Weiss RE, Fontana GP, Forrester J, Makkar RR. Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-CoreValve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients. Catheter Cardiovasc Interv 2012;80:128-38.
15. Smith CR, Leon MB, Mack MJ, et al., for the PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98.
16. Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol 2012;59:113-8.
17. Webb JG, Wood DA. Current status of transcatheter aortic valve replacement. J Am Coll Cardiol 2012;60:483-92.
18. Reynolds MR, Magnuson EA, Lei Y, et al., for the PARTNER Trial Investigators. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation 2011;124:1964-72.
19. Reynolds MR, Magnuson EA, Wang K, et al., for the PARTNER Trial Investigators. Cost effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the PARTNER trial (Cohort B). Circulation 2012;125:1102-9.
20. Cohen D, Reynolds M, Magnuson, et al., for the PARTNER Trial Investigators. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER trial (Cohort A). J Am Coll Cardiol 2012;60:548-58.
21. Kodali S, Williams M, Smith CR, et al., for the PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aorticvalve replacement. N Engl J Med 2012;366:1686-95.
22. Makkar RR, Fontana GP, Jilaihawi H, et al., for the PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012;366:1696-704.
23. Généreux P, Head SJ, Hahn R, et al. Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature. J Am Coll Cardiol 2013:1125-36.
24. Toggweiler S, Humphries KH, Lee M, et al. 5-year outcome after transcatheter aortic valve implantation. JAmColl Cardiol 2013;61:413-9.
25. Webb JG, Dvir D. Transcatheter aortic valve replacement for bioprosthetic aortic valve failure: the valve-in-valve procedure. Circulation 2013;127:2542-50.
26. Miller DC, Blackstone EH, Mack MJ, et al., for the PARTNER Trial Investigators and Patients, PARTNER Stroke Substudy Writing Group and Executive Committee. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg 2012;143:832-843.e13.
27. Mylotte D, Osnabrugge RL, Windecker S, et al. Transcatheter aortic valve implantation in Europe: adoption trends and factors influencing device utilization. J Am Coll Cardiol 2013;62:210-9.
28. Holmes DR Jr., Mack MJ. Transcatheter valve therapy: a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons. J Am Coll Cardiol 2011;58:445-55.
29. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011;57:253-69.
30. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012;60:1438-54.
31. Leon MB, Smith CR, Mack M, et al., for the PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.NEngl J Med 2010;363:1597-607.
32. Smith CR, Leon MB, Mack MJ, et al., for the PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98.
33. Reynolds MR, Magnuson EA, Lei Y, et al., for the PARTNER Trial Investigators. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol 2012;60:2683-92.
34. Reynolds MR, Magnuson EA, Wang K, et al., for the PARTNER Trial Investigators. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol 2012;60: 548-58.
35. Reynolds MR, Magnuson EA, Wang K, et al., for the PARTNER Investigators. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (Cohort B). Circulation 2012;125:1102-9.
36. Kodali SK, Williams MR, Smith CR, et al., for the PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aorticvalve replacement. N Engl J Med 2012;366:1686-95.
37. Makkar RR, Fontana GP, Jilaihawi H, et al., for the PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012;366:1696-704.
38. Leon MB. A randomized evaluation of the SAPIEN XT transcatheter valve system in patients with aortic stenosis who are not candidates for surgery: PARTNER 2, inoperable cohort. Paper presented at: American College of Cardiology Scientific Sessions (ACC) 2013, March 10, 2013, San Francisco, CA.
39. Tommaso CL, Bolman RM 3rd, Feldman T, et al. Multisociety (AATS, ACCF, SCAI, and STS) expert consensus statement: operator and institutional requirements for transcatheter valve repair and replacement, part 1: transcatheter aortic valve replacement. J Am Coll Cardiol 2012;59:2028-42.